The opioid fentanyl affects light input, electrical activity and Per gene expression in the hamster suprachiasmatic nuclei

European Journal of Neuroscience

Volumn 21, Issue 11, 2005, Pages 2958-2966

  Vansteensel, Mariska J ^a   Magnone, Maria Chiara ^b   Van Oosterhout, Floor ^a   Baeriswyl, Stéphanie ^b   Albrecht, Urs ^b   Albus, Henk ^a   Dahan, Albert ^a   Meijer, Johanna H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Addiction; Circadian; Electrophysiology; Entrainment; Pain

Indexed keywords

FENTANYL; NALOXONE; OPIATE; OPIATE RECEPTOR;

ADDICTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CIRCADIAN RHYTHM; CONTROLLED STUDY; ELECTRIC ACTIVITY; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HAMSTER; IN VITRO STUDY; MALE; NEUROPHARMACOLOGY; NONHUMAN; PER GENE; PHOTOSTIMULATION; PRIORITY JOURNAL; SUPRACHIASMATIC NUCLEUS; SYRIAN HAMSTER PERIOD 1 GENE; SYRIAN HAMSTER PERIOD 2 GENE;

ACTION POTENTIALS; ANIMALS; BEHAVIOR, ANIMAL; CELL CYCLE PROTEINS; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; CRICETINAE; FENTANYL; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MALE; MESOCRICETUS; NARCOTIC ANTAGONISTS; NARCOTICS; NEURONS; NUCLEAR PROTEINS; OPIOID-RELATED DISORDERS; ORGAN CULTURE TECHNIQUES; PHOTIC STIMULATION; PHOTOTRANSDUCTION; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION FACTORS;

EID: 21444438697     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04131.x     Document Type: Article

References (79)

1. Abarca, C., Albrecht, U. & Spanagel, R. (2002) Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc. Natl. Acad. Sci. USA, 99, 9026-9030.
2. Albers, H.E. & Ferris, C.F. (1984) Neuropeptide Y: Role in light-dark cycle entrainment of hamster circadian rhythms. Neurosci. Lett., 50, 163-168.
3. Albrecht, U. (2002) Invited review: Regulation of mammalian circadian clock genes. J. Appl. Physiol., 92, 1348-1355.
4. Albrecht, U., Lu, H.C., Revelli, J.P., Xu, X.C., Logan, R. & Eichele, G. (1998) Studying gene expression on tissue sections using in situ hybridization. In Adolph, K.W. (Ed.), Human Genome Methods. CRC Press, Boca Raton, New York, pp. 93-120.
5. Albrecht, U., Sun, Z.S., Eichele, G. & Lee, C.C. (1997) A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell, 91, 1055-1064.
6. Albrecht, U., Zheng, B., Larkin, D., Sun, Z.S. & Lee, C.C. (2001) mPer1 and mPer2 are essential for normal resetting of the circadian clock. J. Biol. Rhythms, 16, 100-104.
7. Allen, C.N., Jiang, Z.G., Teshima, K., Darland, T., Ikeda, M., Nelson, C.S., Quigley, D.I., Yoshioka, T., Allen, R.G., Rea, M.A. & Grandy, D.K. (1999) Orphanin-FQ/Nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons. J. Neurosci., 19, 2152-2160.
8. Andretic, R., Chaney, S. & Hirsh, J, (1999) Requirement of circadian genes for cocaine sensitization in Drosophila. Science, 285, 1066-1068.
9. Arvidsson, U., Riedl, M., Chakrabarti, S., Vulchanova, L., Lee. J.H., Nakano. A.H., Lin, X., Loh, H.H., Law, P.Y., Wessendorf, M.W. & Eide, R. (1995) The κ-opioid receptor is primarily postsynaptic: Combined immunohistochemical localization of the receptor and endogenous opioids. Proc. Natl. Acad. Sci. USA, 92, 5062-5066.
10. Berkowitz, B.A., Ngai, S.H., Hempstead, J. & Spector, S. (1975) Disposition of naloxone; use of a new radioimmunoassay. J. Pharmacol. Exp. Ther., 195, 499-504.
11. Biello, S.M. & Mrosovsky, N. (1995) Blocking the phase-shifting effect of neuropeptide Y with light. Proc. R. Soc. Lond. B, 259, 179-187.
12. Byku, M. & Gannon, R.L. (2000a) Opioid induced non-photic phase shifts of hamster circadian activity rhythms. Brain Res., 873, 189-196.
13. Byku, M. & Gannon, R.L. (2000b) SNC-80, a delta-opioid agonist, elicits phase advances in hamster circadian activity rhythms. Neuroreport, 11, 1449-1452.
14. Byku, M., Legutko, R. & Gannon, R.L. (2000) Distribution of δ opioid receptor immunoreactivity in the hamster suprachiasmatic nucleus and intergeniculate leaflet. Brain Res., 857, 1-7.
15. Chen, J.C., Smith, E.R., Cahill, M., Cohen, R. & Fishman, J.B. (1993) The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci., 52, 389-396.
16. Cox, E.H., Kerbusch, T., Van der Graaf, P.H. & Danhof, M. (1998) Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor. J. Pharmacol. Exp. Ther., 284, 1095-1103.
17. Cutler, D.J., Mundey, M.K. & Mason, R. (1999) Electrophysiological effects of opioid receptor activation on Syrian hamster suprachiasmatic nucleus neurones in vitro. Brain Res. Bull., 50, 119-125.
18. Dahan, A., Sarton, E., Teppema, L., Olievier, C, Nieuwenhuijs, D., Matthes, H.W.D. & Kieffer, B.L. (2001) Anesthetic potency and influence of morphine and sevoflurane on respiration in μ-opioid receptor knockout mice. Anesthesiology. 94, 824-832.
19. De Vries, M.J., Nunes Cardozo, B., van der Want, J., de Wolf, A. & Meijer, J.H. (1993) Glutamate immunoreactivity in terminals of the retinohypothalamic tract of the brown Norwegian rat. Brain Res., 612, 231-237.
20. De Vries, M.J., Treep, J.A., de Pauw, E.S.D. & Meijer, J.H. (1994) The effects of electrical stimulation of the optic nerves and anterior optic chiasm on the circadian activity rhythm of the Syrian hamster: involvement of excitatory amino acids. Brain Res., 642, 206-212.
21. Desjardins, G.C., Brawer, J.R. & Beaudet, A. (1990) Distribution of μ, δ and κ opioid receptors in the hypothalamus of the rat. Brain Res., 536, 114-123.
22. Ding. J.M., Faiman, L.E., Hurst, W.J., Kuriashkma, L.R. & Gillette, M.U. (1997) Resetting the biological clock: mediation of nocturnal CREB phosphorylation via light, glutamate, and nitric oxide. J. Neurosci., 17, 667-675.
23. Ding, Y.Q., Kaneko, T., Nomura, S. & Mizuno, N. (1996) Immunohistochemical localization of μ-opioid receptors in the central nervous system of the rat. J. Comp. Neurol, 367, 375-402.
24. Duggan, A.W. & North, R. A. (1984) Electrophysiology of opioids. Pharmacol. Rev., 35, 219-281.
25. Edelstein, K., de la Iglesia, H.O., Schwartz, W.J. & Mrosovsky, N. (2003) Behavioral arousal blocks light-induced phase advances in locomotor rhythmicity but not light-induced Per1 and FOS expression in the hamster suprachiasmatic nucleus. Neuroscience, 118, 253-261.
26. 7 receptors in the suprachiasmatic nucleus. J. Neurosci., 21, 5351-5357.
27. Fukuhara, C., Brewer, J.M., Dirden, J.C., Bittman, E.L., Tosini, G. & Harrington, M.E. (2001) Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus. Neurosci. Lett., 314, 119-122.
28. George, S.R., Zastawny, R.L., Briones-Urbina, R., Cheng, R., Nguyen, T., Heiber, M., Kouvelas, A., Chan, A.S. & O'Dowd, B.F. (1994) Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem. Biophys. Res. Comm., 205, 1438-1444.
29. Gillette, M.U. & Mitchell, J.W. (2002) Signaling in the suprachiasmatic nucleus: selectively responsive and integrative. Cell Tissue Res., 309, 99-107.
30. Hamada, T., Antle, M.C. & Silver, R. (2004) The role of Period1 in non-photic resetting of the hamster circadian pacemaker in the suprachiasmatic nucleus. Neurosci. Lett., 362, 87-90.
31. 1A/7 receptor agonists accompanied by reduced Per1 and Per2 mRNA levels in the suprachiasmatic nuclei. J. Neurosci., 20, 5867-5873.
32. Lord, J.A.H., Waterfield, A.A., Hughes, J. & Kosterlitz, H.W. (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature. 267, 495-499.
33. Mansour, A., Fox, C.A., Burke, S., Meng, F., Thompson, R.C., Akil, H. & Watson, S.J. (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol., 350, 412-438.
34. Marchant, E.G. & Mistlberger, R.E. (1995) Morphine phase-shifts circadian rhythms in mice: role of behavioural activation. Neuroreport, 7, 209-212.
35. Masubuchi, S., Honma, S., Abe, H., Ishizaki, K., Narnihira, M., Ikeda, M. & Honma, K. (2000) Clock genes outside the suprachiasmatic nucleus involved in manifestation of locomotor activity rhythm in rats. Eur. J. Neurosci., 12, 4206-4214.
36. Matthes, H.W.D., Smadja, C., Valverde, O., Vonesch, J.-L., Foutz, A.S., Boudinot, E., Denavit-Saubié, M., Severini, C., Negri, L., Roques. B.P., Maldonado, R. & Kieffer, B.L. (1998) Activity of the δ-opioid receptor is partially reduced, whereas activity of the κ-receptor is maintained in mice lacking the μ-receptor. J. Neiirosci., 18, 7285-7295.
37. Maywood, E.S. & Mrosovsky, N. (2001) A molecular explanation of interactions between photic and non-photic circadian clock-resetting stimuli. Brain Res. Gene Expr. Patterns, 1, 27-31.
38. Maywood, E.S., Mrosovsky, N., Field, M.D. & Hastings, M.H. (1999) Rapid down-regulation of mammalian Period genes during behavioral resetting of the circadian clock. Proc. Natl. Acad. Sci. USA, 96, 15211-15216.
39. Maywood, E.S., Okamura, H. & Hastings, M.H. (2002) Opposing actions of neuropeptide Y and light on the expression of circadian clock genes in the mouse suprachiasmatic nuclei. Eur. J. Neurosci., 15, 216-220.
40. Meijer, J.H., Ruijs, A.C.J., Albus, H., van de Geest, B., Duindam, H., Zwinderman, A.H. & Dahan, A. (2000) Fentanyl, a μ-opioid receptor agonist, phase shifts the hamster circadian pacemaker. Brain Res., 868, 135-140.
41. Meijer, J.H., Rusak, B. & Gänshirt, G. (1992) The relation between light-induced discharge in the suprachiasmatic nucleus and phase shifts of hamster circadian rhythms. Brain Res., 598, 257-263.
42. Meijer, J.H. & Schwartz, W.J. (2003) In search of the pathways for light-induced pacemaker resetting in the suprachiasmatic nucleus. J. Biol. Rhythms, 18, 235-249.
43. Meijer, J.H. & Takahashi, J.S. (2004) Light responsiveness and photic entrainment of the mammalian circadian clock. In Chalupa, L.M. & Werner, J.S. (Eds), The Visual Neurosciences, Vol. 1. The Mit Press, Cambridge, MA, pp. 625-640.
44. Mendoza, J.Y., Dardente, H., Escobar, C., Pevet, P. & Challet, E. (2004) Dark pulse resetting of the suprachiasmatic clock in Syrian hamsters: behavioral phase-shifts and clock gene expression. Neuroscience, 127, 529-537.
45. Miller, J.D., Morin, L.P., Schwartz, W.J. & Moore, R.Y. (1996) New insights into the mammalian circadian clock. Sleep, 19, 641-667.
46. Minami, M. & Satoh, M. (1995) Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci. Res., 23, 121-145.
47. 14C naloxone in the rat and some comparative observations on nalorphine. J. Pharmacol Exp. Ther., 196, 257-268.
48. Mistlberger, R.E. & Antle, M.C. (1998) Behavioral inhibition of light-induced circadian phase resetting is phase and serotonin dependent. Brain Res., 786, 31-38.
49. Moga, M.M. & Moore, R.Y. (1997) Organization of neural inputs to the suprachiasmatic nucleus in the rat. J. Comp. Neurol, 389, 508-534.
50. Morin, L.P. (1994) The circadian visual system. Brain Res. Rev., 67, 102-127.
51. Morin, L.P. & Blanchard, J.H. (2001) Neuromodulator content of hamster intergeniculate leaflet neurons and their projection to the suprachiasmatic nucleus or visual midbrain. J. Comp. Neurol, 437, 79-90.
52. Moriya, T., Horikawa, K., Akiyama, M. & Shibata, S. (2000) Correlative association between N-methyl-D-aspartate receptor-mediated expression of Period genes in the suprachiasmatic nucleus and phase shifts in behavior with photic entrainment of clock in hamsters. Mol. Pharmacol., 58, 1554-1562.
53. Mrosovsky, N. (1988) Phase response curves for social entrainment. J. Comp. Physiol. A, 162, 35-46.
54. Mrosovsky, N. (1996) Locomotor activity and non-photic influences on circadian clocks. Biol. Rev., 71, 343-372.
55. Nikaido, T., Akiyama, M., Moriya, T. & Shibata, S. (2001) Sensitized increase of Period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine. Mol. Pharmacol., 59, 894-900.
56. O'Neill, S.J., Collins, M.A., Pettit, H.O., McNutt, R.W. & Chang, K.J. (1997) Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice. J. Pharmacol. Exp. Ther., 282, 271-277.
57. Obrietan, K., Impey, S. & Storm, D.R. (1998) Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat. Neurosci., 1, 693-700.
58. Palazzi, E., Ceppi, E., Guglielmetti, F., Catozzi, L., Amoroso, D. & Groppetti, A. (1996) Biochemical evidence of functional interaction between μ- and δ-opioid receptors in SK-N-BE neuroblastoma cell line. J. Neurochem., 67, 138-144.
59. 1B receptor agonists inhibit light-induced phase shifts of behavioral circadian rhythms and expression of the immediate-early gene c-fos in the suprachiasmatic nucleus. J. Neurosci., 16, 8208-8220.
60. Poirel, V.J., Boggio, V, Dardente, H., Pevet, P., Masson-Pevet, M. & Gauer, F. (2003) Contrary to other non-photic cues, acute melatonin injection does not induce immediate changes of clock gene mRNA expression in the rat suprachiasmatic nuclei. Neuroscience, 120, 745-755.
61. Ralph, M.R., Foster, R.G., Davis, F.C. & Menaker, M. (1990) Transplanted suprachiasmatic nucleus determines circadian period. Science, 247, 975-978.
62. Rea, M.A., Glass, J.D. & Colwell, C.S. (1994) Serotonin modulates photic responses in the hamster suprachiasmatic nuclei. J. Neurosci., 14. 3635-3642.
63. Reppert, S.M. & Weaver, D.R. (2002) Coordination of circadian timing in mammals. Nature, 418, 935-941.
64. Schaap, J. & Meijer, J.H. (2001) Opposing effects of behavioural activity and light on neurons of the suprachiasmatic nucleus. Eur. J. Neurosci., 13, 1955-1962.
65. Shearman, L.P., Zylka, M.J., Weaver, D.R., Kolakowski, L.F. Jr & Reppert, S.M. (1997) Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei. Neuron, 19, 1261-1269.
66. Shigeyoshi, Y., Taguchi, K., Yamamoto, S., Takekida, S., Yan, L., Tei, H., Moriya, T, Shibata, S., Loros, J.J., Dunlap, J.C. & Okamura, H. (1997) Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript. Cell, 91, 1043-1053.
67. Spanagel, R., Pendyala, G., Abarca, C., Zghoul, T., Sanchis-Segura, C., Magnone, M.C., Lascorz, J., Depner, M., Holzberg, D., Soyka, M., Schreiber, S., Matsuda, F., Lathrop, M., Schumann, G. & Albrecht, U. (2005) The clock gene Per1 influences the glutamatergic system and modulates alcohol consumption. Nat. Med., 11, 35-42.
68. Sun, Z.S., Albrecht, U., Zhuchenko, O., Bailey, J., Eichele, G. & Lee, C.C. (1997) RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell, 90, 1003-1011.
69. Takahashi, J.S., Turek, F.W. & Moore, R.Y. (2001) Handbook of Behavioral Neurohiology, Vol. 12: Circadian Clocks. Kluwer Academic/Plenum Publishers, New York.
70. Tierao, A., Fiore, P. & Gannon, R.L. (2002) Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms. Brain Res., 937, 66-73.
71. 1A receptor agonists on the circadian rhythm of wheel-running activity in hamsters. Eur. J. Pharmacol., 214, 79-84.
72. Vansteensel, M.J., Deboer, T., Dahan, A. & Meijer, J.H. (2003) Differential responses of circadian activity onset and offset following GABA-ergic and opioid receptor activation. J. Biol. Rhythms, 18, 297-306.
73. Wakamatsu, H., Takahashi, S., Moriya, T., Inouye, S.T., Okamura, H., Akiyama, M. & Shibata, S. (2001) Additive effect of mPer1 and mPer2 antisense oligonucleotides on light-induced phase shift. Neuroreport, 12, 127-131.
74. Weber, E.T. & Rea, M.A. (1997) Neuropeptide Y blocks light-induced phase advances but not delays of the circadian activity rhythm in hamsters. Neurosci. Lett., 231, 159-162.
75. Wee, B.E.F. & Turek, F.W. (1989) Midazolam, a short-acting benzodiazepine, resets the circadian clock of the hamster. Pharmacol. Biochem. Behav., 32, 901-906.
76. Yannielli, P.C., McKinley Brewer, J. & Harrington, M.E. (2002) Is novel wheel inhibition of per1 and per2 expression linked to phase shift occurrence? Neuroscience, 112, 677-685.
77. Yokota, S., Horikawa, K., Akiyama, M., Moriya, T., Ebihara, S., Komuro, G., Ohta, T. & Shibata, S. (2000) Inhibitory action of brotizolam on circadian and light-induced per1 and per2 expression in the hamster suprachiasmatic nucleus. Br. J. Pharmacol., 131, 1739-1747.
78. Yuferov, V., Kroslak, T., Laforge, K.S., Zhou, Y., Ho, A. & Kreek, M.J. (2003) Differential gene expression in the rat caudate putamen after 'binge' cocaine administration: advantage of triplicate microarray analysis. Synapse, 48, 157-169.
79. Zaveri, N., Polgar, W.E., Olsen, C.M., Kelson, A.B., Grundt, P., Lewis, J.W. & Toll, L. (2001) Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors. Eur. J. Pharmacol., 428, 29-36.